31 results on '"Lyytikainen, O."'
Search Results
2. Changing epidemiology of methicillin-resistant Staphylococcus aureus (MRSA) in Finland
- Author
-
Santala, A.-M., Vuopio-Varkila, J., Salmenlinna, S., and Lyytikainen, O.
- Published
- 2003
3. Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis
- Author
-
Cassini, A, Hogberg, LD, Plachouras, D, Quattrocchi, A, Hoxha, A, Simonsen, GS, Colomb-Cotinat, M, Kretzschmar, ME, Devleesschauwer, B, Cecchini, M, Ouakrim, DA, Oliveira, TC, Struelens, MJ, Suetens, C, Monnet, DL, Strauss, R, Mertens, K, Struyf, T, Catry, B, Latour, K, Ivanov, IN, Dobreva, EG, Tambic Andrasevic, A, Soprek, S, Budimir, A, Paphitou, N, Zemlickova, H, Olsen, SS, Sonksen, UW, Martin, P, Ivanova, M, Lyytikainen, O, Jalava, J, Coignard, B, Eckmanns, T, Abu Sin, M, Haller, S, Daikos, GL, Gikas, A, Tsiodras, S, Kontopidou, F, Toth, A, Hajdu, A, Guolaugsson, O, Kristinsson, KG, Murchan, S, Burns, K, Dsstat, PP, Gagliotti, C, Dumpis, U, Liuimiene, A, Perrin, M, Borg, MA, de Greeff, SC, Monen, JCM, Koek, MBG, Elstrom, P, Zabicka, D, Deptula, A, Hryniewicz, W, Canica, M, Nogueira, PJ, Fernandes, PA, Manageiro, V, Popescu, GA, Serban, RI, Schreterova, E, Litvova, S, Stefkovicova, M, Kolman, J, Klavs, I, Korosec, A, Aracil, B, Asensio, A, Perez-Vazquez, M, Billstrom, H, Larsson, S, Reilly, JS, Johnson, A, Hopkins, S, Cassini, A, Hogberg, LD, Plachouras, D, Quattrocchi, A, Hoxha, A, Simonsen, GS, Colomb-Cotinat, M, Kretzschmar, ME, Devleesschauwer, B, Cecchini, M, Ouakrim, DA, Oliveira, TC, Struelens, MJ, Suetens, C, Monnet, DL, Strauss, R, Mertens, K, Struyf, T, Catry, B, Latour, K, Ivanov, IN, Dobreva, EG, Tambic Andrasevic, A, Soprek, S, Budimir, A, Paphitou, N, Zemlickova, H, Olsen, SS, Sonksen, UW, Martin, P, Ivanova, M, Lyytikainen, O, Jalava, J, Coignard, B, Eckmanns, T, Abu Sin, M, Haller, S, Daikos, GL, Gikas, A, Tsiodras, S, Kontopidou, F, Toth, A, Hajdu, A, Guolaugsson, O, Kristinsson, KG, Murchan, S, Burns, K, Dsstat, PP, Gagliotti, C, Dumpis, U, Liuimiene, A, Perrin, M, Borg, MA, de Greeff, SC, Monen, JCM, Koek, MBG, Elstrom, P, Zabicka, D, Deptula, A, Hryniewicz, W, Canica, M, Nogueira, PJ, Fernandes, PA, Manageiro, V, Popescu, GA, Serban, RI, Schreterova, E, Litvova, S, Stefkovicova, M, Kolman, J, Klavs, I, Korosec, A, Aracil, B, Asensio, A, Perez-Vazquez, M, Billstrom, H, Larsson, S, Reilly, JS, Johnson, A, and Hopkins, S
- Abstract
BACKGROUND: Infections due to antibiotic-resistant bacteria are threatening modern health care. However, estimating their incidence, complications, and attributable mortality is challenging. We aimed to estimate the burden of infections caused by antibiotic-resistant bacteria of public health concern in countries of the EU and European Economic Area (EEA) in 2015, measured in number of cases, attributable deaths, and disability-adjusted life-years (DALYs). METHODS: We estimated the incidence of infections with 16 antibiotic resistance-bacterium combinations from European Antimicrobial Resistance Surveillance Network (EARS-Net) 2015 data that was country-corrected for population coverage. We multiplied the number of bloodstream infections (BSIs) by a conversion factor derived from the European Centre for Disease Prevention and Control point prevalence survey of health-care-associated infections in European acute care hospitals in 2011-12 to estimate the number of non-BSIs. We developed disease outcome models for five types of infection on the basis of systematic reviews of the literature. FINDINGS: From EARS-Net data collected between Jan 1, 2015, and Dec 31, 2015, we estimated 671 689 (95% uncertainty interval [UI] 583 148-763 966) infections with antibiotic-resistant bacteria, of which 63·5% (426 277 of 671 689) were associated with health care. These infections accounted for an estimated 33 110 (28 480-38 430) attributable deaths and 874 541 (768 837-989 068) DALYs. The burden for the EU and EEA was highest in infants (aged <1 year) and people aged 65 years or older, had increased since 2007, and was highest in Italy and Greece. INTERPRETATION: Our results present the health burden of five types of infection with antibiotic-resistant bacteria expressed, for the first time, in DALYs. The estimated burden of infections with antibiotic-resistant bacteria in the EU and EEA is substantial compared with that of other infectious diseases, and has increased since 2007. Ou
- Published
- 2019
4. Antimicrobial use in European acute care hospitals: results from the second point prevalence survey (PPS) of healthcare-associated infections and antimicrobial use, 2016 to 2017
- Author
-
Plachouras, D., Karki, T., Hansen, S., Hopkins, S., Lyytikainen, O., Moro, M. L., Reilly, J., Zarb, P., Zingg, W., Kinross, P., Weist, K., Monnet, D. L., Suetens, C., Strauss, R., Presterl, E., Latour, K., Vandael, E., Dobreva, E., Ivanov, I. N., Budimir, A., Bosnjak, Z., Hadjihannas, L., Jindrak, V., Martin, P., Mitt, P., Sarvikivi, E., Daniau, C., Berger-Carbonne, A., Aghdassi, S., Gastmeier, P., Kontopidou, F., Arvaniti, K., Hajdu, A., Gudlaugsson, O., Zotti, C. M., Quattrocolo, F., Burns, K., Dimina, E., Vilde, A., Staniulyte, J., Debacker, M., Arendt, V., Borg, M. A., Hopmans, T., Smid, E., Berg, T. C., Alberg, T., Deptula, A., Rydygier, L., Neves, I., Pacheco, P., Serban, R. I., Niculcea, A. S., Markovic-Denic, L., Dragovac, G., Litvova, S., Stefkovicova, M., Zupanc, T. L., Korosec, A., Asensio, A., Cantero, M., Johnson, A., Sartaj, M., Mcconaghy, M., Cairns, S., Gibbons, C., Nedyalkov, M., Hristova, R., Harrison, W., Florentin, D., Latour, Katrien, Vandael, Eline, and Point Prevalence Survey Study Group
- Subjects
Author's Correction ,0301 basic medicine ,Male ,Epidemiology ,Respiratory Tract Infections/drug therapy/epidemiology ,Anti-Infective Agents/therapeutic use ,antibiotic use ,0302 clinical medicine ,Anti-Infective Agents ,Antibiotics ,Acute care ,Surveys and Questionnaires ,Antimicrobial stewardship ,Pseudomonas aeruginosa infections ,030212 general & internal medicine ,Respiratory Tract Infections ,Tuberculosis -- Case studies ,media_common ,Cross Infection ,Respiratory tract infections ,Drug Utilization/statistics & numerical data ,Hospitals/statistics & numerical data ,Penicillins/therapeutic use ,Antimicrobial ,Hospitals ,Community-Acquired Infections/drug therapy/epidemiology ,3. Good health ,Community-Acquired Infections ,Intensive Care Units ,healthcare-associated infections ,surveillance ,Anti-infective agents ,Infection -- Control ,Female ,beta-Lactamase Inhibitors ,medicine.medical_specialty ,Drug Prescriptions/statistics & numerical data ,030106 microbiology ,Penicillins ,Drug Prescriptions ,Beta-Lactamase Inhibitors/therapeutic use ,03 medical and health sciences ,Surgical prophylaxis ,Virology ,Cross Infection/drug therapy/epidemiology ,point-prevalence survey ,medicine ,media_common.cataloged_instance ,Humans ,antimicrobial use ,hospitals ,European union ,Intensive care medicine ,Adverse effect ,business.industry ,Public Health, Environmental and Occupational Health ,Drug Utilization ,Antimicrobial use ,business - Abstract
Antimicrobial agents used to treat infections are lifesaving. Overuse may result in more frequent adverse effects and emergence of multidrug-resistant microorganisms. In 2016–17, we performed the second pointprevalence survey (PPS) of healthcare-associated infections (HAIs) and antimicrobial use in European acute care hospitals. We included 1,209 hospitals and 310,755 patients in 28 of 31 European Union/European Economic Area (EU/EEA) countries. The weighted prevalence of antimicrobial use in the EU/EEA was 30.5% (95% CI: 29.2–31.9%). The most common indication for prescribing antimicrobials was treatment of a community-acquired infection, followed by treatment of HAI and surgical prophylaxis. Over half (54.2%) of antimicrobials for surgical prophylaxis were prescribed for more than 1 day. The most common infections treated by antimicrobials were respiratory tract infections and the most commonly prescribed antimicrobial agents were penicillins with beta-lactamase inhibitors. There was wide variation of patients on antimicrobials, in the selection of antimicrobial agents and in antimicrobial stewardship resources and activities across the participating countries. The results of the PPS provide detailed information on antimicrobial use in European acute care hospitals, enable comparisons between countries and hospitals, and highlight key areas for national and European action that will support efforts towards prudent use of antimicrobials., peer-reviewed
- Published
- 2018
- Full Text
- View/download PDF
5. Worsening epidemiological situation of carbapenemase-producing Enterobacteriaceae in Europe, assessment by national experts from 37 countries, July 2018
- Author
-
Brolund, A (Brolund, Alma) 1 Lagerqvist, N (Lagerqvist, Nina) 1, 2 Byfors, S (Byfors, Sara) 1 Struelens, MJ (Struelens, Marc J.) 3 Monnet, DL (Monnet, Dominique L.) 3 Albiger, B (Albiger, Barbara) 3 Kohlenberg, A (Kohlenberg, Anke) 3 Apfalter, P (Apfalter, Petra) Hartl, R (Hartl, Rainer) Glupczynski, Y (Glupczynski, Youri) Huang, DTD (Huang, Daniel Te-Din) Ivanov, I (Ivanov, Ivan) Sabtcheva, S (Sabtcheva, Stefana) Pristas, I (Pristas, Irina) Tambic Andrasevic, A (Tambic Andrasevic, Arjana) Maikanti-Charalampous, P (Maikanti-Charalampous, Panagiota) Hrabak, J (Hrabak, Jaroslav) Hammerum, AM (Hammerum, Anette M.) Sonksen, UW (Sonksen, Ute W.) Bilozor, A (Bilozor, Anastasia) Ivanova, M (Ivanova, Marina) Lyytikainen, O (Lyytikainen, Outi) Raisanen, K (Raisanen, Kati) Colomb-Colinat, M (Colomb-Colinat, Melanie) Dortet, L (Dortet, Laurent) Noll, I (Noll, Ines) Pfennigwerth, N (Pfennigwerth, Niels) Vatopoulos, A (Vatopoulos, Alkiviadis) Toth, A (Toth, Akos) Helgason, KO (Helgason, Kristjan Orri) Brennan, W (Brennan, Wendy) Burns, K (Burns, Karen) Monaco, M (Monaco, Monica) Pantosti, A (Pantosti, Annalisa) Savicka, O (Savicka, Oksana) Selderina, S (Selderina, Solvita) Mierauskaite, A (Mierauskaite, Aiste) Perrin, M (Perrin, Monique) Nestorova, N (Nestorova, Nina) Schouls, L (Schouls, Leo) van der Zwaluw, K (van der Zwaluw, Kim) Samuelsen, O (Samuelsen, Orjan) Literacka, E (Literacka, Elzbieta) Zabicka, D (Zabicka, Dorota) Canica, M (Canica, Manuela) Manageiro, V (Manageiro, Vera) Codita, I (Codita, Irina) Popescu, GA (Popescu, Gabriel Adrian) Niks, M (Niks, Milan) Zakova, A (Zakova, Andrea) Pirs, M (Pirs, Mateja) Subelj, M (Subelj, Maja) Campos, J (Campos, Jose) Oteo, J (Oteo, Jesus) Edquist, P (Edquist, Petra) Sjostrom, K (Sjostrom, Karin) Hopkins, K (Hopkins, Katie) Bego, A (Bego, Artan) Koraqi, A (Koraqi, Andi) Travar, M (Travar, Maja) Kurti, A (Kurti, Arsim) Raka, L (Raka, Lul) Lopicic, M (Lopicic, Milena) Vuksanovic, V (Vuksanovic, Vineta) Kaftandziewa, A (Kaftandziewa, Ana) Osmani, D (Osmani, Dugagjin) Cirkovic
- Subjects
stomatognathic system ,urogenital system ,viruses ,KLEBSIELLA-PNEUMONIAEHOSPITAL OUTBREAKRESISTANT ,biochemical phenomena, metabolism, and nutrition - Abstract
A survey on the epidemiological situation, surveillance and containment activities for carbapenemas-eproducing Enterobacteriaceae (CPE) was conducted in European countries in 2018. All 37 participating countries reported CPE cases. Since 2015, the epidemiological stage of CPE expansion has increased in 11 countries. Reference laboratory capability, dedicated surveillance and a specific national containment plan are in existence in 33, 27 and 14 countries, respectively. Enhanced control efforts are needed for CPE containment in Europe.
- Published
- 2018
6. The potential risks and impact of the start of the 2015-2016 influenza season in the WHO European Region: a rapid risk assessment
- Author
-
Tjon‐Kon‐Fat, Raïssa, Meerhoff, Tamara, Nikisins, Sergejs, Pires, João, Pereyaslov, Dmitriy, Gross, Diane, Brown, Caroline, Drishti, A., Hasibra, I., Kota, M., Simaku, A., Sarkisian, S., Torosyan, L., El Belazi, G., Hain, C., Lachner, P., Muchl, R., Popow‐Kraupp, T., Redlberger‐Fritz, M., Strauss, R., Abdullayeva, N., Salimov, O., Gribkova, N., Shimanovich, V., Bossuyt, N., Hombrouck, A., Moreels, S., Thomas, I., an Casteren, ., Bastinac, D., Dedejic Ljubovic, A., Kojic, D., Kovacevic Suljkanovic, M., Kuzmanovic, M., Vukmir Rodic, N., Georgieva, T., Kojouharova, M., Korsun, N., Drazenovic, V., Erceg, M., Kurecic‐Filipovic, S., Simunovic, A., Visekruna, V.V., Bagatzouni, D., Elia, A., Koliou, M., Havlickova, M., Jirincova, H., Kyncl, J., Bragstad, K., Kolsen Fischer, T., Krause, K.L., Mazick, A., Trebbien, R., Dontsenko, I., Dotsenko, L., Pokras, L., Sadikova, O., Ikonen, N., Lyytikainen, O., Murtopuro, S., Ruutu, P., Behillil, S., Belchior, E., Blanchon, T., Bonmarin, I., Bruno, L., Cohen, J.M., Enouf, V., Levy, B.D., Mosnier, A., Turbelin, C., Valette, M., an der Werf, ., Chakhunashvili, G., Machablishvili, A., Zakhashvili, K., Andreas, G., Buda, S., Eckmanns, T., Krause, G., Poggensee, G., Schweiger, B., Kossivakis, A., Malisiovas, N., Mentis, A., Spala, G., Csohan, A., Jankovics, I., Kaszas, K., Molnar, Z., Rozsa, M., Gudnason, T., Löve, A., Sigmundsdottir, G., Coughlan, S., Domegan, L., Duffy, M., Igoe, D., O'Donnell, J., O'Flanagan, D., Waters, A., Kaufman, Z., Mandelboim, M., Bella, A., Donatelli, I., Pompa, M.G., Rizzo, C., Amandosova, D., Kuatbaeva, A., Nusupbaeva, G., Smagulova, M., Smagul, M., Sultanova, M., Otorbaeva, D., Saparova, G., Butirina, R., Nikiforova, R., Storozenko, J., Zamjatina, N., Griskevicius, A., Lipnickiene, V., Muralyte, S., Mossong, J., Opp, M., Barbara, C., Graziella, Z., Maistre, M.J., Melillo, T., Rakocevic, B., Vratnica, Z., Hooiveld, I., de Lange, M., Dijkstra, F., Donker, G., Meijer, A., Rimmelzwaan, G., Teirlinck, A., van der Hoek, W., Dudman, S., Hauge, S.H., Hungnes, O., Kilander, A., Tonnessen, R., Bednarska, K., Brydak, L., Wozniak‐Kosek, A., Zielinski, A., Guiomar, R., Nunes, B., Eder, V., Spinu, C., Alexandrescu, V., Lupulescu, E., Popovici, F., Burtseva, E., Komissarov, A., Smorodintseva, E., Sominina, A., Dimitrijevic, D., Filipovic, S., Staronova, E., Berginc, N., Prosenc, K., Socan, M., Ucakar, V., Grgic Vitek, M., Casas, I., de Lejarazu, R. Ortiz, Larrauri, A., Pozo, F., Vega, T., Ali, M., Brytting, M., Dahl, H., Englund, H., Tegnell, A., Wallensten, A., Wiman, A., Born, R., Cordey, S., Kamolov, M., Bosevska, G., Karadzovski, Z., Kuzmanovska, G., Mikik, V., Korukluoglu, G., Topal, S., Ashyrova, A., Ovliyakulova, G., Demchyshyna, I., Dykhanovska, T., Mironenko, A., Blatchford, O., Carman, W., Coyle, P., Gunson, R., Kearns, C., MacLean, A., Mcmenamin, J., Moore, C., Nugent, C., Pebody, R., Phin, N., Reynolds, A., Smyth, B., Watson, J., Zambon, M., Dzemileva, S., and Rakhimov, R.
- Subjects
0301 basic medicine ,Pulmonary and Respiratory Medicine ,Epidemiology ,Influenza season ,Influenza A(H1N1)pdm09 virus ,influenza A(H1N1)pdm09 virus ,Seasonal influenza ,03 medical and health sciences ,Environmental protection ,Virology ,Environmental health ,Estado de Saúde ,2015–2016 Influenza season ,Public Health, Environmental and Occupational Health ,virus diseases ,1103 Clinical Sciences ,European region ,030112 virology ,Europe ,030104 developmental biology ,Infectious Diseases ,Geography ,1117 Public Health And Health Services ,2015-2016 Influenza season ,Original Article ,seasonal influenza ,Determinantes da Saúde e da Doença ,WHO European Region ,Risk assessment - Abstract
WHO European Region Influenza Network: P.Conde, I. Costa, P. Crostovão, R. Guiomar, B. Nunes, P.Pechirra, A. Rodrigues (Portugal) BACKGROUND: Countries in the World Health Organization (WHO) European Region are reporting more severe influenza activity in the 2015-2016 season compared to previous seasons. OBJECTIVES: To conduct a rapid risk assessment to provide interim information on the severity of the current influenza season METHODS: Using the WHO manual for rapid risk assessment of acute public health events and surveillance data available from Flu News Europe, an assessment of the current influenza season from 28 September 2015 (week 40/2015) up to 31 January 2016 (week 04/2016) was made compared with the 4 previous seasons. RESULTS: The current influenza season started around week 51/2015 with higher influenza activity reported in eastern Europe compared to Western Europe. There is a strong predominance of influenza A(H1N1)pdm09 compared to previous seasons, but the virus is antigenically similar to the strain included in the seasonal influenza vaccine. Compared to the 2014/2015 season, there was a rapid increase in the number of severe cases in eastern European countries with the majority of such cases occurring among adults aged
- Published
- 2016
7. Increased incidence of Mycoplasma pneumoniae infection in Finland, 2010-2011
- Author
-
University of Helsinki, Department of Virology, Polkowska, A., Harjunpaa, A., Toikkanen, S., Lappalainen, M., Vuento, R., Vuorinen, T., Kauppinen, J., Flinck, H., Lyytikainen, O., University of Helsinki, Department of Virology, Polkowska, A., Harjunpaa, A., Toikkanen, S., Lappalainen, M., Vuento, R., Vuorinen, T., Kauppinen, J., Flinck, H., and Lyytikainen, O.
- Published
- 2012
8. Infection control--a European research perspective for the next decade.
- Author
-
Dettenkofer, M., Ammon, A., Astagneau, P., Dancer, S.J., Gastmeier, P., Harbarth, S., Humphreys, H., Kern, W.V., Lyytikainen, O., Sax, H., Voss, A., Widmer, A.F., Dettenkofer, M., Ammon, A., Astagneau, P., Dancer, S.J., Gastmeier, P., Harbarth, S., Humphreys, H., Kern, W.V., Lyytikainen, O., Sax, H., Voss, A., and Widmer, A.F.
- Abstract
1 januari 2011, Item does not contain fulltext, A symposium was held in June 2009 near Freiburg in Germany. Twenty-nine attendees from several European countries participated, most of whom are actively involved in research and hospital infection prevention and control. The following topics were presented and discussed: isolation and screening for control of multidrug-resistant organisms; impact of the environment on healthcare-associated infection (HAI); new technologies to control infection--state of evidence; surveillance of HAI; methodological challenges and research priorities for infection control and control of HAI: learning from each other in a united Europe. This Leader summarises the main issues for debate and the number of consensus points agreed amongst delegates.
- Published
- 2011
9. National hand hygiene campaigns in Europe, 2000-2009.
- Author
-
Magiorakos, A.P., Suetens, C., Boyd, L., Costa, C., Cunney, R., Drouvot, V., Farrugia, C., Fernandez-Maillo, M.M., Iversen, B.G., Leens, E., Michael, S., Moro, M.L., Reinhardt, C., Serban, R., Vatcheva-Dobrevska, R., Wilson, K., Heisbourg, E., Maltezou, H.C., Strauss, R., Borocz, K., Dolinsek, M., Dumpis, U., Erne, S., Gudlaugsson, O., Heczko, P.B., Hedlova, D., Holt, J., Joe, L., Lyytikainen, O., Riesenfeld-Orn, I., Stefkovikova, M., Valinteliene, R., Voss, A., Monnet, D.L., Magiorakos, A.P., Suetens, C., Boyd, L., Costa, C., Cunney, R., Drouvot, V., Farrugia, C., Fernandez-Maillo, M.M., Iversen, B.G., Leens, E., Michael, S., Moro, M.L., Reinhardt, C., Serban, R., Vatcheva-Dobrevska, R., Wilson, K., Heisbourg, E., Maltezou, H.C., Strauss, R., Borocz, K., Dolinsek, M., Dumpis, U., Erne, S., Gudlaugsson, O., Heczko, P.B., Hedlova, D., Holt, J., Joe, L., Lyytikainen, O., Riesenfeld-Orn, I., Stefkovikova, M., Valinteliene, R., Voss, A., and Monnet, D.L.
- Abstract
Item does not contain fulltext, Hand hygiene represents the single most effective way to prevent healthcare-associated infections. The World Health Organization, as part of its First Global Patient Safety Challenge, recommends implementation of multi-faceted strategies to increase compliance with hand hygiene. A questionnaire was sent by the European Centre for Disease Prevention and Control to 30 European countries, regarding the availability and organisation of their national hand hygiene campaigns. All countries responded. Thirteen countries had organised at least one national campaign during the period 2000-2009 and three countries were in the process of organising a national campaign. Although the remaining countries did not have a national campaign, several reported regional and local hand hygiene activities or educational resources on national websites.
- Published
- 2009
10. Isolation rooms for highly infectious diseases: an inventory of capabilities in European countries
- Author
-
Fusco, F M, Puro, V, Baka, A, Bannister, B, Brodt, H-R, Brouqui, P, Follin, P, Gjorup, I E, Gottschalk, R, Hemmer, R, Hoepelman, I M, Jarhall, B, Kutsar, K, Lanini, S, Lyytikainen, O, Maltezou, H C, Mansinho, K, Marti, M C, Ott, K, Peleman, R, Perronne, C, Sheehan, G, Siikamakii, H, Skinhøj, Peter, Trilla, A, Vetter, N, Ippolito, G, Fusco, F M, Puro, V, Baka, A, Bannister, B, Brodt, H-R, Brouqui, P, Follin, P, Gjorup, I E, Gottschalk, R, Hemmer, R, Hoepelman, I M, Jarhall, B, Kutsar, K, Lanini, S, Lyytikainen, O, Maltezou, H C, Mansinho, K, Marti, M C, Ott, K, Peleman, R, Perronne, C, Sheehan, G, Siikamakii, H, Skinhøj, Peter, Trilla, A, Vetter, N, and Ippolito, G
- Abstract
Udgivelsesdato: 2009-Sep, Isolation of patients with highly infectious diseases (HIDs) in hospital rooms with adequate technical facilities is essential to reduce the risk of spreading disease. The European Network for Infectious Diseases (EUNID), a project co-funded by European Commission and involving 16 European Union member states, performed an inventory of high level isolation rooms (HIRs, hospital rooms with negative pressure and anteroom). In participating countries, HIRs are available in at least 211 hospitals, with at least 1789 hospital beds. The adequacy of this number is not known and will depend on prevailing circumstances. Sporadic HID cases can be managed in the available HIRs. HIRs could also have a role in the initial phases of an influenza pandemic. However, large outbreaks due to natural or to bioterrorist events will need management strategies involving healthcare facilities other than HIRs.
- Published
- 2009
11. Antimicrobial drug use and resistance in Europe
- Author
-
van de Sande-Bruinsma, Nienke, Grundmann, Hajo, Verloo, Didier, Tiemersma, Edine, Monen, Jos, Goossens, Herman, Ferech, Matus, Mittermayer, H., Metz, S., Koller, W., Hendrickx, E., Goossens, H., Markova, B., Tambic-Andrasevic, A., Francetic, I., Kalenic, S., Bagatzouni, D., Dvorak, P., Urbaskova, P., Monnet, D., Nielsen, A.A., Naaber, P., Houvinen, P., Paakkari, P., Lyytikainen, O., Nissinen, A., Maugendre, P., Guillemot, D., Coignard, B., Jarlier, V., Kern, W., Schroeder, H., Witte, W., Heckenbach, K., Giamarellou, H., Antoniadou, A., Tsakris, A., Vatopoulos, A., Ternak, G., Fuzi, M., Kristinsson, K., Smyth, E., Cunney, R., Igoe, D., Murphy, O., Raz, R., Cornaglia, G., Pantosti, A., D´Ancona, P., Berzina, S., Balode, A., Valenteliene, R., Miciulevicience, J., Hemmer, R., Bruch, M., Borg, M., Zarb, P., Janknegt, R., Filius, M., de Neeling, H., Tiemermsa, E., Degener, J., Blix, H.S., Hoiby, A., Simonsen, G., Hryniewicz, W., Grzesiowski, P., Caldeira, L., Canica, M., Codita, I., Foltan, V., Tesar, T., Langsadl, L., Cizman, M., Mueller-Premru, M., Kolman, J., Campos, J., Baguero, F., Cars, Otto, Skoog, G., Liljequist, B., Kahlmeter, G., Unal, S., Gür, D., Davey, P., Johnson, A., Hughes, H., Coyne, M., van de Sande-Bruinsma, Nienke, Grundmann, Hajo, Verloo, Didier, Tiemersma, Edine, Monen, Jos, Goossens, Herman, Ferech, Matus, Mittermayer, H., Metz, S., Koller, W., Hendrickx, E., Goossens, H., Markova, B., Tambic-Andrasevic, A., Francetic, I., Kalenic, S., Bagatzouni, D., Dvorak, P., Urbaskova, P., Monnet, D., Nielsen, A.A., Naaber, P., Houvinen, P., Paakkari, P., Lyytikainen, O., Nissinen, A., Maugendre, P., Guillemot, D., Coignard, B., Jarlier, V., Kern, W., Schroeder, H., Witte, W., Heckenbach, K., Giamarellou, H., Antoniadou, A., Tsakris, A., Vatopoulos, A., Ternak, G., Fuzi, M., Kristinsson, K., Smyth, E., Cunney, R., Igoe, D., Murphy, O., Raz, R., Cornaglia, G., Pantosti, A., D´Ancona, P., Berzina, S., Balode, A., Valenteliene, R., Miciulevicience, J., Hemmer, R., Bruch, M., Borg, M., Zarb, P., Janknegt, R., Filius, M., de Neeling, H., Tiemermsa, E., Degener, J., Blix, H.S., Hoiby, A., Simonsen, G., Hryniewicz, W., Grzesiowski, P., Caldeira, L., Canica, M., Codita, I., Foltan, V., Tesar, T., Langsadl, L., Cizman, M., Mueller-Premru, M., Kolman, J., Campos, J., Baguero, F., Cars, Otto, Skoog, G., Liljequist, B., Kahlmeter, G., Unal, S., Gür, D., Davey, P., Johnson, A., Hughes, H., and Coyne, M.
- Abstract
Our study confronts the use of antimicrobial agents in ambulatory care with the resistance trends of 2 major pathogens, Streptococcus pneumoniae and Escherichia coli, in 21 European countries in 2000-2005 and explores whether the notion that antimicrobial drug use determines resistance can be supported by surveillance data at national aggregation levels. The data obtained from the European Surveillance of Antimicrobial Consumption and the European Antimicrobial Resistance Surveillance System suggest that variation of consumption coincides with the occurrence of resistance at the country level. Linear regression analysis showed that the association between antimicrobial drug use and resistance was specific and robust for 2 of 3 compound pathogen combinations, stable over time, but not sensitive enough to explain all of the observed variations. Ecologic studies based on routine surveillance data indicate a relation between use and resistance and support interventions designed to reduce antimicrobial drug consumption at a national level in Europe.
- Published
- 2008
- Full Text
- View/download PDF
12. Risk of invasive pneumococcal infections among working age adults with asthma
- Author
-
Klemets, P., primary, Lyytikainen, O., additional, Ruutu, P., additional, Ollgren, J., additional, Kaijalainen, T., additional, Leinonen, M., additional, and Pekka Nuorti, J., additional
- Published
- 2010
- Full Text
- View/download PDF
13. P265 Development of a multi-national population-based bacteremia surveillance collaborative
- Author
-
Laupland, K., primary, Schonheyder, H., additional, Kennedy, K., additional, Lyytikainen, O., additional, Valiquette, L., additional, Galbraith, J., additional, Collignon, P., additional, Church, D., additional, Gregson, D., additional, and Kibsey, P., additional
- Published
- 2009
- Full Text
- View/download PDF
14. P5.01 Costs of an Outbreak of Methicillin-Resistant Staphylococcus aureus
- Author
-
Kanerva, M., primary, Blom, M., additional, Tuominen, U., additional, Kolho, E., additional, Anttila, V.J., additional, Vaara, M., additional, Virolainen-Julkunen, A., additional, and Lyytikainen, O., additional
- Published
- 2006
- Full Text
- View/download PDF
15. P17.80 Use of Antimicrobials in Finnish Acute Care Hospitals - Data from National Prevalence Survey, 2005
- Author
-
Kanerva, M., primary, Lyytikainen, O., additional, Möttönen, T., additional, and Agthe, N., additional
- Published
- 2006
- Full Text
- View/download PDF
16. Nosocomial bloodstream infections due to viridans streptococci in haematological and non-haematological patients: species distribution and antimicrobial resistance
- Author
-
Lyytikainen, O., primary
- Published
- 2004
- Full Text
- View/download PDF
17. Immunodetection of Pneumocystis carinii in bronchoalveolar lavage specimens compared with methenamine silver stain
- Author
-
Lautenschlager, I, primary, Lyytikainen, O, additional, Jokipii, L, additional, Jokipii, A, additional, Maiche, A, additional, Ruutu, T, additional, Tukiainen, P, additional, and Ruutu, P, additional
- Published
- 1996
- Full Text
- View/download PDF
18. Persistence of a Multiresistant Clone of Staphylococcus epidermidis in a Neonatal Intensive-Care Unit for a Four-Year Period
- Author
-
Lyytikainen, O., primary, Saxen, H., additional, Ryhanen, R., additional, Vaara, M., additional, and Vuopio-Varkila, J., additional
- Published
- 1995
- Full Text
- View/download PDF
19. Nosocomial Bloodstream Infections in Finnish Hospitals during 1999-2000.
- Author
-
Lyytikainen, O., Lumio, J., Sarkkinen, H., Kolho, E., Kostiala, A., and Ruutu, P.
- Subjects
- *
NOSOCOMIAL infections , *BLOODBORNE infections , *HOSPITALS - Abstract
Explores the prevalence of nosocomial bloodstream infection (BSI) in hospitals in Finland between 1999 and 2000. Pathogens responsible for BSI; Incidence of BSI; Rate of nosocomial BSI.
- Published
- 2002
20. Exposure of Listeria monocytogenes within an epidemic caused by butter in Finland
- Author
-
Maijala, R., Lyytikainen, O., Johansson, T., Autio, T., Aalto, T., Haavisto, L., and Honkanen-Buzalski, T.
- Published
- 2001
- Full Text
- View/download PDF
21. Surveillance of influenza in Finland during the 2009 pandemic, 10 May 2009 to 8 March 2010
- Author
-
Lyytikainen O, Kuusi M, Snellman M, Virtanen M, Eskola J, Ronkko E, Ikonen N, Ilkka Julkunen, Ziegler T, and Ruutu P
- Subjects
Adult ,Aged, 80 and over ,Male ,Adolescent ,Incidence ,Infant, Newborn ,Infant ,Middle Aged ,Hospitalization ,Young Adult ,Age Distribution ,Influenza A Virus, H1N1 Subtype ,Risk Factors ,Child, Preschool ,Population Surveillance ,Influenza, Human ,Humans ,Female ,Seasons ,Morbidity ,Sex Distribution ,Child ,Pandemics ,Finland ,Aged
22. A pilot validation in 10 European Union Member States of a point prevalence survey of healthcare-associated infections and antimicrobial use in acute hospitals in Europe, 2011.
- Author
-
Reilly JS, Price L, Godwin J, Cairns S, Hopkins S, Cookson B, Malcolm W, Hughes G, Lyytikainen O, Coignard B, Hansen S, and Suetens C
- Subjects
- Anti-Bacterial Agents therapeutic use, Bacterial Infections drug therapy, Croatia epidemiology, Cross Infection etiology, Cross Infection microbiology, Drug Resistance, Microbial, Drug Utilization Review methods, Europe epidemiology, European Union, Female, Health Surveys, Hospitals statistics & numerical data, Humans, Male, Middle Aged, Pilot Projects, Prevalence, Reproducibility of Results, Sensitivity and Specificity, Anti-Bacterial Agents administration & dosage, Bacterial Infections epidemiology, Bacterial Infections etiology, Cross Infection drug therapy, Cross Infection epidemiology, Drug Prescriptions statistics & numerical data, Drug Utilization Review statistics & numerical data
- Abstract
We present a pilot validation study performed on 10 European Union (EU) Member States, of a point prevalence survey (PPS) of healthcare-associated infections (HAIs) and antimicrobial use in Europe in 2011 involving 29 EU/European Economic Area (EEA) countries and Croatia. A total of 20 acute hospitals and 1,950 patient records were included in the pilot study, which consisted of validation and inter-rater reliability (IRR) testing using an in-hospital observation approach. In the validation, a sensitivity of 83% (95% confidence interval (CI): 79–87%) and a specificity of 98% (95% CI: 98–99%) were found for HAIs. The level of agreement between the primary PPS and validation results were very good for HAIs overall (Cohen’s κappa (κ):0.81) and across all the types of HAIs (range: 0.83 for bloodstream infections to 1.00 for lower respiratory tract infections). Antimicrobial use had a sensitivity of 94% (95% CI: 93–95%) and specificity of 97% (95% CI: 96–98%) with a very good level of agreement (κ:0.91). Agreement on other demographic items ranged from moderate to very good (κ: 0.57–0.95): age (κ:0.95), sex (κ: 0.93), specialty of physician (κ: 0.87) and McCabe score (κ: 0.57). IRR showed a very good level of agreement (κ: 0.92) for both the presence of HAIs and antimicrobial use. This pilot study suggested valid and reliable reporting of HAIs and antimicrobial use in the PPS dataset. The lower level of sensitivity with respect to reporting of HAIs reinforces the importance of training data collectors and including validation studies as part of a PPS in order for the burden of HAIs to be better estimated.
- Published
- 2015
- Full Text
- View/download PDF
23. Reduced cross-protection against influenza A(H3N2) subgroup 3C.2a and 3C.3a viruses among Finnish healthcare workers vaccinated with 2013/14 seasonal influenza vaccine.
- Author
-
Haveri A, Ikonen N, Julkunen I, Kantele A, Anttila V, Ruotsalainen E, Nohynek H, Lyytikainen O, and Savolainen-Kopra C
- Subjects
- Adult, Aged, Cross Reactions, Female, Finland, Humans, Infant, Influenza A Virus, H3N2 Subtype classification, Influenza A Virus, H3N2 Subtype genetics, Influenza A Virus, H3N2 Subtype isolation & purification, Influenza, Human immunology, Influenza, Human virology, Male, Middle Aged, Phylogeny, Seasons, Sentinel Surveillance, Vaccination, Young Adult, Antibodies, Viral immunology, Health Personnel, Influenza A Virus, H3N2 Subtype immunology, Influenza Vaccines immunology, Influenza, Human prevention & control
- Published
- 2015
- Full Text
- View/download PDF
24. Agreement among healthcare professionals in ten European countries in diagnosing case-vignettes of surgical-site infections.
- Author
-
Birgand G, Lepelletier D, Baron G, Barrett S, Breier AC, Buke C, Markovic-Denic L, Gastmeier P, Kluytmans J, Lyytikainen O, Sheridan E, Szilagyi E, Tacconelli E, Troillet N, Ravaud P, and Lucet JC
- Subjects
- Europe, Humans, Physicians, Quality Assurance, Health Care, Clinical Competence, Cross Infection, Health Personnel, Surgical Wound Infection diagnosis
- Abstract
Objective: Although surgical-site infection (SSI) rates are advocated as a major evaluation criterion, the reproducibility of SSI diagnosis is unknown. We assessed agreement in diagnosing SSI among specialists involved in SSI surveillance in Europe., Methods: Twelve case-vignettes based on suspected SSI were submitted to 100 infection-control physicians (ICPs) and 86 surgeons in 10 European countries. Each participant scored eight randomly-assigned case-vignettes on a secure online relational database. The intra-class correlation coefficient (ICC) was used to assess agreement for SSI diagnosis on a 7-point Likert scale and the kappa coefficient to assess agreement for SSI depth on a three-point scale., Results: Intra-specialty agreement for SSI diagnosis ranged across countries and specialties from 0.00 (95%CI, 0.00-0.35) to 0.65 (0.45-0.82). Inter-specialty agreement varied from 0.04 (0.00-0.62) in to 0.55 (0.37-0.74) in Germany. For all countries pooled, intra-specialty agreement was poor for surgeons (0.24, 0.14-0.42) and good for ICPs (0.41, 0.28-0.61). Reading SSI definitions improved agreement among ICPs (0.57) but not surgeons (0.09). Intra-specialty agreement for SSI depth ranged across countries and specialties from 0.05 (0.00-0.10) to 0.50 (0.45-0.55) and was not improved by reading SSI definition., Conclusion: Among ICPs and surgeons evaluating case-vignettes of suspected SSI, considerable disagreement occurred regarding the diagnosis, with variations across specialties and countries.
- Published
- 2013
- Full Text
- View/download PDF
25. Influenza-associated hospitalisations in Finland from 1996 to 2010: unexpected age-specific burden during the influenza A(H1N1)pdm09 pandemic from 2009 to 2010.
- Author
-
Jacks A, Ollgren J, Ziegler T, and Lyytikainen O
- Subjects
- Adolescent, Adult, Age Distribution, Aged, Child, Child, Preschool, Disease Notification statistics & numerical data, Finland epidemiology, Humans, Incidence, Infant, Infant, Newborn, Influenza, Human diagnosis, Influenza, Human prevention & control, Middle Aged, Models, Biological, Registries, Seasons, Sentinel Surveillance, Cost of Illness, Hospitalization statistics & numerical data, Influenza A Virus, H1N1 Subtype, Influenza, Human epidemiology, Pandemics
- Abstract
To assess the burden of influenza on the Finnish healthcare system, we analysed hospitalisations during 1996-2010 using the International Classification of Diseases codes potentially related to influenza and its complications from the national hospital discharge registry. To compare the influenza A(H1N1)pdm09 pandemic with previous influenza seasons in 1996-2009, we calculated hospitalisation rates by age- and diagnostic groups. We built a negative binomial regression model based on times series analysis to assess the impact of the pandemic. Influenza-associated hospitalisation rates were higher during the pandemic compared to pre-pandemic influenza seasons for 5-24 year-olds (incidence rate ratio (IRR): 1.52, 95% confidence interval (CI): 1.44-1.60) and 25-64 year-olds (IRR: 1.33, 95% CI: 1.29-1.36), but did not differ for persons aged ≥ 65 years (IRR: 0.98, 95% CI: 0.97-1.00). Hospitalisation rates exceeded the upper limit of the prediction line by 177% in 5-24 year-olds, 66% in 0-4 year-olds and 57% in 25-64 year-olds. During the influenza season of 2003/04, all age groups had higher-than-expected hospitalisation rates, whereas other seasonal peaks were only notable among persons aged ≥ 65 years. These age-specific differences in the hospital burden underscore the importance of the continuous surveillance of hospitalisations in order to evaluate immunisation priorities for seasonal influenza and pandemic preparedness including use of antiviral medication.
- Published
- 2012
26. Surveillance of influenza in Finland during the 2009 pandemic, 10 May 2009 to 8 March 2010.
- Author
-
Lyytikainen O, Kuusi M, Snellman M, Virtanen M, Eskola J, Ronkko E, Ikonen N, Julkunen I, Ziegler T, and Ruutu P
- Subjects
- Adolescent, Adult, Age Distribution, Aged, Aged, 80 and over, Child, Child, Preschool, Female, Finland epidemiology, Hospitalization statistics & numerical data, Humans, Incidence, Infant, Infant, Newborn, Influenza, Human mortality, Male, Middle Aged, Morbidity, Risk Factors, Seasons, Sex Distribution, Young Adult, Influenza A Virus, H1N1 Subtype isolation & purification, Influenza, Human epidemiology, Influenza, Human virology, Pandemics, Population Surveillance methods
- Published
- 2011
27. National hand hygiene campaigns in Europe, 2000-2009.
- Author
-
Magiorakos AP, Suetens C, Boyd L, Costa C, Cunney R, Drouvot V, Farrugia C, Fernandez-Maillo MM, Iversen BG, Leens E, Michael S, Moro ML, Reinhardt C, Serban R, Vatcheva-Dobrevska R, Wilson K, Heisbourg E, Maltezou HC, Strauss R, Borocz K, Dolinsek M, Dumpis U, Erne S, Gudlaugsson O, Heczko P, Hedlova D, Holt J, Joe L, Lyytikainen O, Riesenfeld-Orn I, Stefkovikova M, Valinteliene R, Voss A, and Monnet DL
- Subjects
- Europe, Humans, Communicable Disease Control methods, Communicable Disease Control statistics & numerical data, Hand Disinfection methods, Health Promotion organization & administration, Health Promotion statistics & numerical data, Hygiene
- Abstract
Hand hygiene represents the single most effective way to prevent healthcare-associated infections. The World Health Organization, as part of its First Global Patient Safety Challenge, recommends implementation of multi-faceted strategies to increase compliance with hand hygiene. A questionnaire was sent by the European Centre for Disease Prevention and Control to 30 European countries, regarding the availability and organisation of their national hand hygiene campaigns. All countries responded. Thirteen countries had organised at least one national campaign during the period 2000-2009 and three countries were in the process of organising a national campaign. Although the remaining countries did not have a national campaign, several reported regional and local hand hygiene activities or educational resources on national websites.
- Published
- 2009
28. A widespread outbreak of Yersinia pseudotuberculosis O:3 infection from iceberg lettuce.
- Author
-
Nuorti JP, Niskanen T, Hallanvuo S, Mikkola J, Kela E, Hatakka M, Fredriksson-Ahomaa M, Lyytikainen O, Siitonen A, Korkeala H, and Ruutu P
- Subjects
- Adolescent, Adult, Aged, Case-Control Studies, Child, Child, Preschool, Female, Finland epidemiology, Hospitalization statistics & numerical data, Humans, Male, Middle Aged, Yersinia pseudotuberculosis Infections transmission, Disease Outbreaks, Food Microbiology, Lactuca microbiology, Yersinia pseudotuberculosis Infections epidemiology
- Abstract
Background: The vehicles and sources of Yersinia pseudotuberculosis infection are unknown. In Finland, clinical microbiology laboratories routinely report Y. pseudotuberculosis isolations and submit isolates for serotype analysis. In October 1998, the number of serotype O:3 infections increased markedly., Methods: Case patients with culture-confirmed Y. pseudotuberculosis O:3 infection were identified by use of laboratory-based surveillance. We conducted a population-based case-control study. Healthy community control subjects were matched by age, sex, and postal code. Isolates were subtyped by pulsed-field gel electrophoresis (PFGE)., Results: Nationwide, 47 case patients were identified (age range, 2-77 years; median, 19 years). One patient with bacteremia died; 5 underwent appendectomies. We enrolled 38 case patients and 76 control subjects in the case-control study. Seventy-one percent of case patients and 42% of control subjects reported having eaten iceberg lettuce (matched odds ratio, 3.8; 95% confidence interval, 1.3-9.4); a dose-response relationship was found for increasing frequency of consumption. Of the 27 isolates obtained from case patients and tested in the analysis, all had indistinguishable PFGE patterns. Four lunch cafeterias that had served iceberg lettuce were associated with clusters of case patients. The lettuce was traced back to originating farms., Conclusions: Iceberg lettuce was implicated as the vehicle of a widespread foodborne Y. pseudotuberculosis outbreak. Ongoing laboratory-based surveillance and serotype analysis were essential in the rapid detection of infection. Cases of yersiniosis, which appear to be sporadic, may be part of unrecognized outbreaks caused by contaminated fresh produce.
- Published
- 2004
- Full Text
- View/download PDF
29. Outbreak oof calicivirus gastroenteritis associated with eating frozen raspberries.
- Author
-
Ponka A, Maunula L, Von Bonsdorff CH, and Lyytikainen O
- Abstract
Small round structured viruses (SRSVs - for example, calici-, astro-, and entero-viruses) are the commonest causes of outbreaks of non-bacterial gastroenteritis worldwide. Transmission of SRSVs by water and by various foods - including salads, bakery prod
- Published
- 1999
- Full Text
- View/download PDF
30. Community-wide outbreak of enteroviral illness caused by echovirus 30: a cross-sectional survey and a case-control study.
- Author
-
Reintjes R, Pohle M, Vieth U, Lyytikainen O, Timm H, Schreier E, and Petersen L
- Subjects
- Adolescent, Case-Control Studies, Child, Child, Preschool, Cross-Sectional Studies, Disease Outbreaks, Echovirus Infections virology, Germany epidemiology, Humans, Infant, Infant, Newborn, Meningitis, Aseptic virology, Risk Factors, Echovirus Infections epidemiology, Enterovirus B, Human isolation & purification, Meningitis, Aseptic epidemiology
- Abstract
Background: In June, 1997, 21 children from a single community in Germany were hospitalized with aseptic meningitis. An epidemiologic investigation was conducted to determine the extent of the outbreak and risk factors for illness., Method: The extent of the outbreak was assessed with a cross-sectional survey of every 10th child listed in the town register among the 2240 town children < 16 years old. A case-control study determined risk factors for illness. Sixty-two cases were identified through the cross-sectional survey from hospitalized persons and from persons seen by local physicians. Controls were 114 asymptomatic persons identified from the cross-sectional survey., Results: The overall attack rate was 16%, with the highest attack rates (24%) among the 6- to 8-year olds. Onsets occurred during a 37-day period. Among the 2240 town children <16 years of age, an estimated 353 met the case definition for enteroviral illness, 168 visited a doctor and 21 were hospitalized. Data from the case-control study indicated that contact with an ill household member [odds ratio (OR) = 6.3; 95% confidence interval (CI) 2.6 to 15.5], day-care attendance (OR = 2.6; 95% CI 1.1 to 6.2) and playground use, either two to three times per week (OR = 3.7; 95% CI 1.3 to 10.2) or daily (OR = 4.3; 95% CI 1.6 to 11.3), were risk factors for illness., Conclusion: Echovirus 30 caused substantial morbidity during this community outbreak caused by person-to-person spread. Household contacts, day-care centers and playgrounds were prominent risk factors for transmission.
- Published
- 1999
- Full Text
- View/download PDF
31. Outbreak of Q fever in Lohra-Rollshausen, Germany, spring 1996.
- Author
-
Lyytikainen O, Ziese T, Schwartlander B, Matzdorff P, Kuhnhen C, Burger C, Krug W, and Petersen LR
- Abstract
Q fever is an acute (and sometimes chronic) febrile illness caused by the rickettsial organism Coxiella burnetii. The commonest animal reservoirs for C. burnetiiare cattle, sheep, and goats. Infected animals shed the organisms, which resist desiccation, i
- Published
- 1997
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.